Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
02 1AVAPRO
03 1BANZEL
04 1BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
05 1BOSULIF
06 6DEFERASIROX
07 1DISULFIRAM
08 1DUAVEE
09 1EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
10 2GLIMEPIRIDE
11 3IRBESARTAN
12 3IRBESARTAN AND HYDROCHLOROTHIAZIDE
13 1IRBESARTAN; HYDROCHLOROTHIAZIDE
14 1LOVASTATIN
15 1MALARONE
16 1MALARONE PEDIATRIC
17 1MEFLOQUINE HYDROCHLORIDE
18 1PRANDIMET
19 1RAPAMUNE
20 2REPAGLINIDE
21 1REPAGLINIDE AND METFORMIN HYDROCHLORIDE
22 2SIROLIMUS
23 2TADALAFIL
24 1VALSARTAN
01 120757
02 221078
03 121110
04 121911
05 122247
06 122386
07 175991
08 176392
09 176631
10 177159
11 177369
12 177370
13 177911
14 178555
15 191211
16 191367
17 191563
18 1200624
19 2201524
20 1201578
21 1201676
22 1203020
23 1203341
24 1203685
25 1206956
26 1206957
27 1207018
28 1207209
29 1209223
30 1210555
31 1210649
32 1211641
33 1211824
34 1211852
35 1212669
01 35No
02 2Yes
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Drug : AVAPRO
Dosage Form : TABLET; ORAL
Application Number : 20757
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : SIROLIMUS
Dosage Form : TABLET; ORAL
Application Number : 201578
Country : US
Patented : No
Drug : BANZEL
Dosage Form : TABLET; ORAL
Application Number : 21911
Country : US
Patented : No
ATOVAQUONE; PROGUANIL HYDROCHLORIDE
Drug : ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 91211
Country : US
Patented : No
METFORMIN HYDROCHLORIDE; REPAGLINIDE
Drug : PRANDIMET
Dosage Form : TABLET; ORAL
Application Number : 22386
Country : US
Patented : No
Drug : GLIMEPIRIDE
Dosage Form : TABLET; ORAL
Application Number : 77370
Country : US
Patented : No
Drug : TADALAFIL
Dosage Form : TABLET; ORAL
Application Number : 206956
Country : US
Patented : No
HYDROCHLOROTHIAZIDE; IRBESARTAN
Drug : IRBESARTAN AND HYDROCHLOROTHIAZIDE
Dosage Form : TABLET; ORAL
Application Number : 207018
Country : US
Patented : No
Drug : IRBESARTAN
Dosage Form : TABLET; ORAL
Application Number : 203020
Country : US
Patented : No
Drug : TADALAFIL
Dosage Form : TABLET; ORAL
Application Number : 206957
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
